201 related articles for article (PubMed ID: 19888537)
1. Variable effects of alpha v suppression on VEGFR-2 expression in endothelial cells of different vascular beds.
Dardik R; Livnat T; Seligsohn U
Thromb Haemost; 2009 Nov; 102(5):975-82. PubMed ID: 19888537
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia and vascular endothelial growth factor stimulate angiogenic integrin expression in bovine retinal microvascular endothelial cells.
Suzuma K; Takagi H; Otani A; Honda Y
Invest Ophthalmol Vis Sci; 1998 May; 39(6):1028-35. PubMed ID: 9579483
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of vascular endothelial growth factor receptors (VEGFR) revealed by RNA interference: interactions of VEGFR-1 and VEGFR-2 in endothelial cell signaling.
Kou R; SenBanerjee S; Jain MK; Michel T
Biochemistry; 2005 Nov; 44(45):15064-73. PubMed ID: 16274253
[TBL] [Abstract][Full Text] [Related]
4. Use of RNA interference to inhibit integrin subunit alphaV-mediated angiogenesis.
Graef T; Steidl U; Nedbal W; Rohr U; Fenk R; Haas R; Kronenwett R
Angiogenesis; 2005; 8(4):361-72. PubMed ID: 16400518
[TBL] [Abstract][Full Text] [Related]
5. Expression and regulation of neuropilins and VEGF receptors by TNF-alpha in human endothelial cells.
Yang H; Li M; Chai H; Yan S; Zhang R; Yao Q; Chen C
J Surg Res; 2004 Dec; 122(2):249-55. PubMed ID: 15555625
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Rac1 GTPase downregulates vascular endothelial growth factor receptor-2 expression by suppressing Sp1-dependent DNA binding in human endothelial cells.
Meissner M; Michailidou D; Stein M; Hrgovic I; Kaufmann R; Gille J
Exp Dermatol; 2009 Oct; 18(10):863-9. PubMed ID: 19469899
[TBL] [Abstract][Full Text] [Related]
7. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms underlying the proangiogenic effect of factor XIII.
Dardik R; Loscalzo J; Eskaraev R; Inbal A
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):526-32. PubMed ID: 15618543
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
[TBL] [Abstract][Full Text] [Related]
10. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
[TBL] [Abstract][Full Text] [Related]
12. Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development.
Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Uemura M; Fukui H
Oncol Rep; 2005 May; 13(5):853-7. PubMed ID: 15809749
[TBL] [Abstract][Full Text] [Related]
13. Antisense integrin alphaV and beta3 gene therapy suppresses subcutaneously implanted hepatocellular carcinomas.
Li J; Tan H; Dong X; Xu Z; Shi C; Han X; Jiang H; Krissansen GW; Sun X
Dig Liver Dis; 2007 Jun; 39(6):557-65. PubMed ID: 17374519
[TBL] [Abstract][Full Text] [Related]
14. GATA-1 binding to the alphaV promoter negatively regulates expression of the integrin alphaV subunit in human leukemic K562 cells.
Czyz M; Stasiak M; Boncela J; Cierniewsk CS
Acta Biochim Pol; 2002; 49(1):19-28. PubMed ID: 12136940
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profile of vascular endothelial growth factor (VEGF) and its receptors in various cell types of the canine lymph node using laser capture microdissection (LCM).
Jais A; Klein D; Wolfesberger B; Walter I
Vet Immunol Immunopathol; 2011 Apr; 140(3-4):207-14. PubMed ID: 21211854
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiogenesis in vitro by alphav integrin-directed antisense oligonucleotides.
Kronenwett R; Gräf T; Nedbal W; Weber M; Steidl U; Rohr UP; Möhler T; Haas R
Cancer Gene Ther; 2002 Jul; 9(7):587-96. PubMed ID: 12082459
[TBL] [Abstract][Full Text] [Related]
17. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF.
Dardik R; Inbal A
Exp Cell Res; 2006 Oct; 312(16):2973-82. PubMed ID: 16914140
[TBL] [Abstract][Full Text] [Related]
18. Neuropilin-1 modulates vascular endothelial growth factor-induced poly(ADP-ribose)-polymerase leading to reduced cerebrovascular apoptosis.
Mey L; Hörmann M; Schleicher N; Reuter P; Dönges S; Kinscherf R; Gassmann M; Gerriets T; Al-Fakhri N
Neurobiol Dis; 2013 Nov; 59():111-25. PubMed ID: 23816753
[TBL] [Abstract][Full Text] [Related]
19. AlphaV integrins play an important role in myofibroblast differentiation.
Lygoe KA; Norman JT; Marshall JF; Lewis MP
Wound Repair Regen; 2004; 12(4):461-70. PubMed ID: 15260812
[TBL] [Abstract][Full Text] [Related]
20. VEGF189 stimulates endothelial cells proliferation and migration in vitro and up-regulates the expression of Flk-1/KDR mRNA.
Hervé MA; Buteau-Lozano H; Mourah S; Calvo F; Perrot-Applanat M
Exp Cell Res; 2005 Sep; 309(1):24-31. PubMed ID: 15996656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]